The Heterogeneous Prognosis Of Patients With Myelodysplastic Syndrome (MDS) And Chromosome 5 Abnormalities: How Does It Relate To The Original Lenalidomide Experience in MDS?

PURPOSE: To define the prognosis in myelodysplastic syndrome and deletion 5q with or without other cytogenetic abnormalities. PATIENTS AND METHODS: Patients with MDS (<20% blasts) and evaluable cytogenetic studies (1966-present) were reviewed. Outcome of patients with deletion 5q or with loss of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kantarjian, Hagop, O’Brien, Susan, Ravandi, Farhad, Borthakur, Gautam, Faderl, Stefan, Bueso-Ramos, Carlos, Abruzzo, Lynne, Pierce, Sherry, Shan, Jianqin, Issa, Jean-Pierre, Garcia-Manero, Guillermo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783477/
https://ncbi.nlm.nih.gov/pubmed/19691096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24575
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia